Filing Details
- Accession Number:
- 0001225208-15-004547
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 17:48:44
- Reporting Period:
- 2015-02-13
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 17:48:44
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
9892 | Bard C R Inc | BCR | Surgical & Medical Instruments & Apparatus (3841) | 221454160 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1204663 | H John Weiland | C/O C. R. Bard, Inc. 730 Central Avenue Murray Hill NJ 07974 | President And Coo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2015-02-13 | 1,483 | $174.59 | 109,068 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-02-17 | 7,630 | $174.92 | 101,438 | No | 4 | F | Direct | |
Common Stock | Disposition | 2015-02-17 | 13,616 | $174.51 | 87,822 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | F | Direct | |
No | 4 | F | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 5,745 | Indirect | 401(k) Plan |
Footnotes
- Shares withheld to pay taxes upon vesting of restricted stock granted under the Company's 2003 Long Term Incentive Plan.
- Shares withheld to pay taxes upon vesting of restricted stock units acquired through deferral of compensation under the Company's Management Stock Purchase Program.
- Sales are pursuant to a previously disclosed 10b5-1 plan.
- Represents the weighted average sales price for price increments ranging from $174.09 to $174.88. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions reported on this Form 4.